- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Genetics Institute Inc.
Headquarters: United States
Website: N/A
Year Founded: N/A
Status: Out of Business
BioCentury | Mar 11, 2021
Regulation
Tivozanib, at last, is Aveo’s first approved drug in the U.S.
More than $200M and a new Phase III trial later, tivozanib reaches the market for kidney cancer
BioCentury | May 20, 2017
Strategy
Henri: N of 1
How the late Genzyme CEO Henri Termeer created the Orphan drug industry
BioCentury | Jan 20, 2017
Emerging Company Profile
Aiming for durability
Avrobio’s cell therapies have long-term potential in Fabry’s disease, AML
BioCentury | Mar 9, 2015
Finance
Column's creations
How The Column Group's long-term strategy yielded three wins
Items per page:
1 - 10 of 153